ArticleJournal of epidemiology and global health2026
Rising Mortality from Sleep Apnea and Hypertension in U.S. Adults: A 23-Year Epidemiological Analysis And Impact of the COVID-19 Pandemic (2000-2023).
Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObstructive Sleep Apnea (OSA) and hypertension (HTN) are prevalent, interrelated conditions associated with significant cardiovascular morbidity. Despite their rising burden, mortality trends for their co-occurrence remain underexplored.
objectiveTo assess U.S. mortality trends related to OSA and HTN from 2000 to 2023, analyzing demographic, geographic, and temporal patterns.
methodsMortality data for adults aged ≥ 25 were extracted from the CDC WONDER database. Age-adjusted mortality rates (AAMRs) per 100,000 and annual percent changes (APCs) were calculated using joinpoint regression, stratified by sex, race/ethnicity, age, urbanization, and Census regions.
resultsFrom 2000 to 2023, 127,668 deaths were attributed to OSA and HTN. AAMRs rose from 0.44 (95% CI: 0.41–0.47) in 2000 to 4.87 (95% CI: 4.79–4.96) in 2023, with an average annual percent change of + 11.55% (95% CI: 10.41–12.70). Men had higher mortality rates than women (2023: 7.05 vs. 3.05). Non-Hispanic Black adults exhibited the highest AAMRs, followed by Non-Hispanic Whites and Hispanics. Adults ≥ 65 years accounted for 62.4% of deaths. Rural areas had higher mortality than metropolitan areas (2.04 vs. 1.69). States like Oregon had rates nearly five times higher than New York. Mortality peaked in 2018–2021, aligning with the COVID-19 pandemic. Heart disease was the leading underlying cause.
conclusionsOSA and HTN-related mortality has surged over two decades, with pronounced disparities by sex, race, age, and region. Targeted prevention, screening, and intervention strategies are urgently needed, particularly for elderly, minority, and rural populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.